A quantitative test kit for simultaneous measurement of cardiac troponin I (cTnI), creatine kinase-MB (CK-MB), and myoglobin (MYO) levels in patient samples using TRFIA methodology.
Manufactured by
Lumigenex (Suzhou) Co., Ltd
Suzhou Jiangsu, China
Lumigenex is a nanotechnology-driven provider of POCT products for clinical laboratories, doctor's offices, and at-home tests. It specializes in the development and manufacturing of quantitative POCT analyzers and diagnostic kits based on its proprietary TRFIA platform to detect cardiac diseases, metabolic diseases, women's health conditions, and infectious diseases. We also offer dry chemistry analyzers and reagents to manage chronic diseases by measuring lipids, glucose, creatinine , uric acid, homocysteine, and kidney function indicators, including uric acid/creatinine /urea . In addition, a wide range of veterinary quantitative tests are available, with superior quality standards.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
NewScen Coast Bio-Pharmaceutical Co., Ltd.
China · 6 relevant products
Jiangsu Medomics Medical Technology Co.,Ltd.
China · 1 relevant product
Shandong Kanghua Biotechnology Co.,Ltd.
China · 1 relevant product
67 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 111 closest product alternatives
NewScen Coast Bio-Pharmaceutical Co., Ltd. · China
Rapid test kit for simultaneous detection of cardiac troponin I (cTnI), myoglobin, and creatine kinase-MB (CK-MB) markers. Designed for quick diagnosis of acute myocardial infarction and cardiac injury in clinical and emergency settings. Delivers results in minutes to support timely patient management.
Jiangsu Medomics Medical Technology Co.,Ltd. · China
A combination rapid test kit for simultaneous detection of cardiac troponin I (cTnI), myoglobin (Myo), and creatine kinase-MB (CK-MB). This multiplex test supports cardiac biomarker assessment for heart attack and myocardial injury detection.
Shandong Kanghua Biotechnology Co.,Ltd. · China
Immunofluorescence-based combined test kit for simultaneous detection of cardiac biomarkers cTnI, CK-MB, and myoglobin. Designed for rapid cardiac injury assessment in acute coronary syndrome diagnosis and risk stratification. Enables multi-marker analysis from a single sample for improved clinical decision-making.
108 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products